Additionally, Egr-1 has been found to influence the expression of BAX and BCL2 in pancreatic cancer cells, with an increase in BAX and a decrease in BCL2 observed in multiple experimental conditions [66]. The gene discussed is BCL2; the disease is pancreatic neoplasm.